About this trial
Prospective multicenter registry study to assess the frequency of Lynch syndrome among patients with colorectal cancer in Russia
Eligibility criteria
Qualifiers
Provision of written informed consent;
Patients with histologically verified colon adenocarcinoma or patients with histologically verified synchronous neoplasms who have not previously received treatment for a second tumor;
Age ≥ 18 years;
Absence of antitumor treatment for a real tumor (it is allowed to include patients who have a history of antitumor treatment for other malignant tumors, if the period after treatment is more than 12 months).
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
State Scientific Centre of Coloproctology, Russian Federation
Lead sponsor
The Loginov MCSC MHD
Collaborator
Pirogov National Medical and Surgical Center
Collaborator
Moscow City Oncological Hospital No. 62 MHD
Collaborator
City Clinical Oncological Hospital No. 1 MHD
Collaborator
Moscow Multidisciplinary Clinical Center "Kommunarka"
Collaborator
D.D. Pletnev City Clinical Hospital MHD
Collaborator
Botkin Hospital MHD
Collaborator
Clinic K+31
Collaborator